SEC 8-K
SEC 8-K: Item 1.01, 9.01
Official SEC filing update. Items: 1.01, 9.01.
Item 1.01, 9.01Accession 0001493152-24-000339
Official SEC filings
ENDONOVO THERAPEUTICS, INC. SEC Filings and Updates
A filing-level feed of official SEC EDGAR updates collected by Billiver. This page shows metadata and source links only; full filing text opens on SEC.gov.
ENDONOVO THERAPEUTICS, INC. Official SEC Updates
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Open SEC filing
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001493152-23-046444
SEC 8-K
SEC 8-K: Item 1.01, 9.01
Official SEC filing update. Items: 1.01, 9.01.
Item 1.01, 9.01Accession 0001493152-23-043516
SEC 8-K
SEC 8-K: Item 8.01, 9.01
Official SEC filing update. Items: 8.01, 9.01.
Item 8.01, 9.01Accession 0001493152-23-036971
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001493152-23-029706
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001493152-23-018538
SEC 10-K
SEC 10-K
Official SEC filing update.
10-KAccession 0001493152-23-012553
SEC 8-K
SEC 8-K: Item 1.01, 9.01
Official SEC filing update. Items: 1.01, 9.01.
Item 1.01, 9.01Accession 0001493152-23-009376
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001493152-22-033118
SEC 8-K
SEC 8-K: Item 1.01, 9.01
Official SEC filing update. Items: 1.01, 9.01.
Item 1.01, 9.01Accession 0001493152-22-026882
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001493152-22-023661
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001493152-22-014380
SEC 10-K
SEC 10-K
Official SEC filing update.
10-KAccession 0001493152-22-009861
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001493152-21-029295
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001493152-21-020979
Source: SEC EDGAR · 15 filings
Informational only. Not investment advice.